A. Guitarte Vidaurre, Y. Dulac, F. Bajanca, M. Langeois, E. Garrigue, B. Chesneau, T. Edouard
{"title":"MARFANPOWER: Results of a home-based cardiorespiratory and muscle rehabilitation program for children and young adults with Marfan syndrome","authors":"A. Guitarte Vidaurre, Y. Dulac, F. Bajanca, M. Langeois, E. Garrigue, B. Chesneau, T. Edouard","doi":"10.1016/j.acvd.2024.07.037","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Marfan or associated syndromes (MFS) are some rare genetic diseases leading to a multisystem damage related to connective tissue fragility. Chronic fatigue and decreased physical endurance are almost constant complaints of patients with MFS. Muscle mass worsens through adolescence, which could explain the bone-mass deficit observed in this population.</p></div><div><h3>Objective</h3><p>We hypothesize that a personalized exercise rehabilitation program will improve fitness and quality of life (QoL) of these patients.</p></div><div><h3>Methods</h3><p>Self-controlled study with a 6-month home-based cyclo-ergometer and muscular strengthening personalised rehabilitation program based on first ventilatory-threshold. Baseline evaluation was performed 3<!--> <!-->months prior to the start of the rehabilitation program, then at the beginning of the rehabilitation program and at 6<!--> <!-->months, with a mid-term evaluation at 3<!--> <!-->months.</p></div><div><h3>Results</h3><p>We included 28 MFS patients between 7 and 20<!--> <!-->years (mean 12.8<!--> <!-->±<!--> <!-->3.69<!--> <!-->years), of which 11 were females, with a mild aortic dilatation for 50% (mean z-score +2.4), no major valvopathy, no cardiac impairment and a history of pneumothorax for 3 of them; most where under preventive beta-blocker treatment (93%).</p><p>After a 6-month rehabilitation program no progression in aortic diameters was found. Significant improvement in first ventilatory-threshold was achieved (+15.8% of expected value; <em>P</em> <!--><<!--> <!-->0.05), alongside an increase in maximal sustained workload with a mean of +24.5 Watts (17.37–31.63; <em>P</em> <!--><<!--> <!-->0.05) associated to a significant increase in VO<sub>2</sub> (+131.58<!--> <!-->mL.min<sup>−1</sup>; 30.17–232.99; <em>P</em> <!--><<!--> <!-->0.05), whereas maximal heart rate at effort was reduced by 29.95 bpm (16.17–43.73; <em>P</em> <!--><<!--> <!-->0.05). Muscular strength gain was shown both by dominant hand-grip (mean +4.3<!--> <!-->kg; 2.45–5.2; <em>P</em> <!--><<!--> <!-->0.05) and dominant leg strength (+67.33<!--> <!-->Nm; 25.08–109.59; <em>P</em> <!--><<!--> <!-->0.05). Overall, self and proxy-reported QoL of participants improved (<span><span>Fig. 1</span></span>).</p></div><div><h3>Conclusion</h3><p>Young patients with MFS can safely benefit for a home-based rehabilitation program personalised according to their baseline capacities, improving both their overall fitness, muscular strength and cardiovascular health; with a favourable impact in their global QoL.</p></div>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875213624002584","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Marfan or associated syndromes (MFS) are some rare genetic diseases leading to a multisystem damage related to connective tissue fragility. Chronic fatigue and decreased physical endurance are almost constant complaints of patients with MFS. Muscle mass worsens through adolescence, which could explain the bone-mass deficit observed in this population.
Objective
We hypothesize that a personalized exercise rehabilitation program will improve fitness and quality of life (QoL) of these patients.
Methods
Self-controlled study with a 6-month home-based cyclo-ergometer and muscular strengthening personalised rehabilitation program based on first ventilatory-threshold. Baseline evaluation was performed 3 months prior to the start of the rehabilitation program, then at the beginning of the rehabilitation program and at 6 months, with a mid-term evaluation at 3 months.
Results
We included 28 MFS patients between 7 and 20 years (mean 12.8 ± 3.69 years), of which 11 were females, with a mild aortic dilatation for 50% (mean z-score +2.4), no major valvopathy, no cardiac impairment and a history of pneumothorax for 3 of them; most where under preventive beta-blocker treatment (93%).
After a 6-month rehabilitation program no progression in aortic diameters was found. Significant improvement in first ventilatory-threshold was achieved (+15.8% of expected value; P < 0.05), alongside an increase in maximal sustained workload with a mean of +24.5 Watts (17.37–31.63; P < 0.05) associated to a significant increase in VO2 (+131.58 mL.min−1; 30.17–232.99; P < 0.05), whereas maximal heart rate at effort was reduced by 29.95 bpm (16.17–43.73; P < 0.05). Muscular strength gain was shown both by dominant hand-grip (mean +4.3 kg; 2.45–5.2; P < 0.05) and dominant leg strength (+67.33 Nm; 25.08–109.59; P < 0.05). Overall, self and proxy-reported QoL of participants improved (Fig. 1).
Conclusion
Young patients with MFS can safely benefit for a home-based rehabilitation program personalised according to their baseline capacities, improving both their overall fitness, muscular strength and cardiovascular health; with a favourable impact in their global QoL.
期刊介绍:
The Journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles and editorials. Topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.